Journal of Medical Screening

Papers
(The median citation count of Journal of Medical Screening is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
“DNA tests for every baby on the NHS”47
Validation of a monoclonal unconjugated estriol antibody for use in prenatal maternal serum screening30
Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review24
Aptima HPV E6/E7 mRNA and cytology cross-sectional performance as primary screening tests for detection of high-grade cervical lesions in HIV positive and negative women in South Africa23
Provincial variation and associated factors in adherence to cervical cancer screening in Canada: Evidence from the Canadian Partnership for Tomorrow's Health21
Simulated arbitration of discordance between radiologists and artificial intelligence interpretation of breast cancer screening mammograms20
Risk stratification in medical screening19
An economic scenario analysis of implementing artificial intelligence in BreastScreen Norway–Impact on radiologist person-years, costs and effects18
Prediction model to prioritize colorectal cancer screening with visual colonoscopy17
Cell-free DNA screening for sex chromosome aneuploidy in 67,099 pregnancies: A retrospective analysis16
Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality11
Timely adherence to follow-up after high-risk lung cancer screenings10
Comparing screening based on the NHS Health Check and Polypill Prevention Programmes in the primary prevention of heart attacks and strokes9
Applying the healthcare failure mode and effects analysis approach to improve the quality of an organised colorectal cancer screening programme9
Carrier rate of thalassemia among 25,910 high school students in Shaoguan area, China9
Equity challenges in bowel cancer screening: A decade of spoilt faecal immunochemical test kit data in New Zealand8
Percentage mammographic density or absolute breast density for risk stratification in breast screening: Possible implications for socioeconomic health disparity8
Universal newborn hearing screening in Malaysian public hospitals: A national evaluation of coverage, quality indicators, and outcomes (2022–2023)7
Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing7
Thanks to reviewers7
Response to the letter: “Ethics of screening promotion: A slippery slope to forced marketing?”7
Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study7
The Risk-Screening Converter: Use of multiple risk factors7
The Risk-Screening Converter6
Folic acid and neural tube defects: Discovery, debate and the need for policy change6
Public cervical cancer screening recommendations from US cancer centers: Assessing adherence to national guidelines6
Effects of COVID-19 pandemic on breast cancer screening: A 6-year cohort study6
Cancer screening programs in Japan: Progress and challenges6
Feasibility of population-based screening of sickle cell disease through the primary health care system in tribal areas of India5
Trends in colorectal cancer screening in the United States, 2012 to 20205
Age at breast cancer screening in women with intellectual disability5
Cancer screening after the age of 75: Nationwide population-based trends5
Response to Takahashi regarding Bestwick and Wald: Mischaracterisation of evidence in prostate cancer screening5
Factors associated with women's supplemental screening intentions following dense breast notification in an online randomised experimental study5
Effects of health education on screening rate of first-degree relatives of cancer patients: A systematic review and meta-analysis5
Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes in Alberta, Canada5
“It's cancer screening after all”. Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening5
Differential impact of test performance characteristics on burden-to-benefit tradeoffs for blood-based colorectal cancer screening: A microsimulation analysis4
Colorectal cancer screening with faecal immunochemical test: Patterns of participation4
Interval cancer after two rounds of a Swedish population-based screening program using gender-specific cut-off levels in fecal immunochemical test4
Response to ‘Six-week postnatal cervical screening: Moving from acceptability toward mechanistic evidence and policy change’4
Prevalence of colorectal cancer and breast cancer screening according to history of diabetes in 2010–20194
Positive predictive value metrics for multicancer detection tests4
Including the method of detection for breast cancer in the Surveillance, Epidemiology, and End Results database is long overdue4
Attitudes towards being offered a choice of self-sampling or clinician sampling for cervical screening: A cross-sectional survey of women taking part in a clinical validation of HPV self-collection de4
Comments on “Effects of COVID-19 pandemic on breast cancer screening” by Huang et al. https://doi.org/10.1177/096914132513384564
Skin cancer screening recommendations by U.S. cancer centers: Inconsistency with national guidelines3
Is GP practice bowel, breast and cervical cancer screening coverage correlated with GP practice list inflation?3
Thanks to reviewers3
Assessment of the value of polygenic risk scores in the prevention of disease3
The Consensus Project: Participation in cervical cancer screening by the first cohorts of girls offered HPV vaccination at age 15–16 years in Italy3
The impact on clinical outcomes and healthcare resources from discontinuing colonoscopy surveillance subsequent to low-risk adenoma removal: A simulation study using the OncoSim-Colorectal model3
Overcoming barriers to lung cancer screening using a systemwide approach with additional focus on the non-screened3
Poisson regression with adjustment for contamination and non-compliance in cohort studies conducted to estimate intervention effectiveness3
Quality indicators for cervical screening in Sweden3
Beneficial effect of repeated participation in breast cancer screening upon survival3
Age-specific differences in tumour characteristics between screen-detected and non-screen-detected breast cancers in women aged 40–74 at diagnosis in Sweden from 2008 to 20173
Lymphoproliferative disease detected by breast cancer screening2
Long-term colorectal cancer incidence in a post-endoscopic screening cohort, accounting for surveillance, by baseline polyp group, anatomic subsite, and sex2
Anxiety and disease awareness in individuals with heredity for abdominal aortic aneurysm2
The recalibration and redevelopment of a model to calculate patients’ probability of completing a colonoscopy following an abnormal fecal test2
Response to: “The new NHS England ‘ping and book’ screening service is set to exclude thousands of women” https://doi.org/10.1177/096914132513164292
Primary care outreach and decision counseling for lung cancer screening2
Awareness and knowledge about HPV and primary HPV screening among women in Great Britain: An online population-based survey2
Combining genetic and non-genetic risk factors to predict disease, and reporting the screening performance of risk models2
Factors associated with private or public breast cancer screening attendance in Queensland, Australia: A retrospective cross-sectional study2
Improving access to cervical cancer screening: The impact of a Saturday pap smear clinic2
Is it feasible to enhance quality assurance of cervical cancer screening in Latin America? A regional expert consensus2
Changes in quality of life in colorectal cancer screening: A multicentre trial in populations in China2
Primary human papillomavirus testing by clinician- versus self-collection: Awareness and acceptance among cervical cancer screening-eligible women2
The polypill in the primary prevention of heart attacks and strokes: Overcoming barriers to implementation2
Real-world impact of organised mammography screening on breast cancer mortality: A population-based case–control study2
Lung cancer screening programs can contribute significantly to the incidental identification of esophageal cancer in a high-risk population2
Repeat invitations and participation in cervical screening: A population-based cohort study2
Cost-effectiveness of low-dose computed tomography for lung cancer screening in India: A Markov modelling study1
Couple screening for autosomal recessive inherited diseases: Current and historical perspectives1
Racial and ethnic disparities in prostate cancer screening following the 2018 US Preventive Services Task Force recommendation statement1
Newborn screening for biliary atresia using direct bilirubin: An implementation science study1
Investigating the acceptability of cervical screening, using conventional clinician-taken cervical samples or urine self-sampling, at 6 weeks postnatal: A cross-sectional questionnaire1
Advanced disease at presentation for Canadian patients with colorectal cancer despite provincial screening programs: A call to action1
Design and rationale of the ZORALCS study: An implementation study of lung cancer screening by low-dose computed tomography coupled to a smoking cessation randomized controlled trial in the Flemish re1
Examining breast cancer screening recommendations in Canada: The projected resource impact of screening among women aged 40–491
Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up study1
Ripple effect of temporary self-sampling HPV test on screening uptake in the next round: A secondary analysis of the ACCESS randomized controlled trial1
Clinical performance and utility: A microsimulation model to inform the design of screening trials for a multi-cancer early detection test1
Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland1
Postscript to ‘Folic acid and neural tube defects: Discovery, debate and the need for policy change’1
Racial/ethnic and socioeconomic disparities in colorectal cancer screening in a large organization with universal insurance before and during the coronavirus disease 2019 pandemic1
A retrospective cohort study investigating factors affecting recommendation for continued low-dose computed tomography lung cancer screening in the national lung cancer screening trial1
Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme1
The co-creation of a document to guide the use of self-sampling for human papillomavirus screening in Italy1
Adjusting for non-compliance and contamination with a more plausible assumption1
Guidance on terminology1
Newborn screening for abnormal haemoglobins in Jamaica: Practical issues in an island programme1
Impact of frailty and comorbidity on initial response to lung cancer screening invitation and low-dose CT screening uptake: Findings from the Yorkshire Lung Screening Trial1
Long-term cause of death patterns and mode of breast cancer detection in The Netherlands, 2004−20191
Ethics of screening promotion: A slippery slope to forced marketing?1
How follow-up rates in cervical cancer screening depend on organizational factors: A comparison of two population-based organized screening programmes1
Availability of data for cost-effectiveness comparison of child vision and hearing screening programmes1
The new NHS England ‘ping and book’ screening service is set to exclude thousands of women1
Prostate cancer screening: The level of the evidence hierarchy1
On the role and limitations of ChatGPT-based models in breast cancer detection with mammography1
Factors affecting young women's participation in organized cervical cancer screening and non-organized testing – A population-based survey study1
Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing1
Risk of cancer versus risk of cancer diagnosis? Accounting for diagnostic bias in predictions of breast cancer risk by race and ethnicity1
Variation in fecal hemoglobin concentrations: Cross-sectional analysis of a screening trial and a screening program in Sweden1
Retrospective analysis of clinician and patient factors associated with unsatisfactory Pap tests1
0.057693004608154